Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Non-Current Deferred Tax Liability of $53.5 million for Q1 2026, down 1.36% quarter-over-quarter from $54.2 million in Q4 2025.
Lantheus Holdings (LNTH) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $53.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $53.5 million; the TTM figure through Mar 2026 stood at $53.5 million (changed N/A YoY), while the FY2025 annual figure was $54.2 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability declined to $53.5 million in Q1 2026 per LNTH's latest filing, from $54.2 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $55.1 million in Q3 2025 and bottomed at $53.5 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.06 Mn |
| Jun 30, 2026 | 54.06 Mn |
| Mar 31, 2026 | 53.51 Mn |
| Mar 31, 2026 | 53.51 Mn |
| Dec 31, 2025 | 54.25 Mn |
| Dec 31, 2025 | 54.25 Mn |
| Sep 30, 2025 | 55.08 Mn |
| Sep 30, 2025 | 55.08 Mn |
| Dec 31, 2016 | 33.20 Mn |
| Dec 31, 2016 | 33.20 Mn |
| Mar 31, 2016 | 200,000.00 |
| Mar 31, 2016 | 200,000.00 |
| Dec 31, 2015 | 32.90 Mn |
| Dec 31, 2015 | 32.90 Mn |
| Dec 31, 2014 | 247,000.00 |
| Dec 31, 2014 | 247,000.00 |